Dr. Bethany Angela Roehm, MD

Dr. Roehm practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Roehm's NPI, 1689054330, was assigned on June 8, 2015. Dr. Roehm graduated from Texas A&M College of Medicine - Bryan in 2015. Dr. Roehm holds Texas license T1826.

Dr. Roehm's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Roehm's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roehm practices. Vendor and product names are available with a free account.

Nephrology is Dr. Roehm's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Roehm is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Roehm's licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Roehm treats.

CMS data shows 308 Medicare services from Dr. Roehm across 7 procedure codes in 2024, for 155 Medicare patients. Medicare paid $22,716 for them.

CMS counts 155 Medicare patients who saw Dr. Roehm in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 3.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roehm's median patient age at 66, with 52% women.

In 2024, Dr. Roehm wrote 427 Medicare Part D claims for 96 patients. 78% of them were for generic drugs. CMS names the drug for 315 of them, across 12 drugs with 11 or more claims each, at $68,416 in total drug cost. In 2023, CMS named 158 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Roehm for performance year 2024, reported as part of a group. Dr. Roehm accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roehm as offering telehealth.

Dmand AI links 15 papers to Dr. Roehm, published from 2017 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Heart Failure, Glomerular Filtration Rate and Heart-Assist Devices. Dr. Roehm has published most often in Am J Kidney Dis. Dr. Roehm's most frequent co-authors are Justin Lee Grodin, MD, Gaurav Gulati, MD and Jonathan Gordon, MD.

CMS Open Payments shows 2 general payments to Dr. Roehm from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. NxStage Medical, Inc. paid the most, $39.

Dr. Roehm graduated from Texas A&M College of Medicine - Bryan in 2015.

Dr. Roehm is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.